DCH — Dauch Corporation · 2026-09-05 · Verdict: WATCH · Conviction 3

Price $6.67 (screen row, 2026-09-04 build; no live prices) · Mkt cap $1,585M (237.6M sh) · EV ~$5,730M · 51.9x stale CY2025 EV/EBIT vs 4.1x EV/guided Adj EBITDA · Screen FCF yield 9.8% (stale) · Net debt $4,145M · ADV $18.5M · 25.9% off 52-week high Sources: 10-K 2026-02-13 (Items 1, 1A, 7), 10-Q 2026-08-07, DEF 14A 2026-03-19, 8-Ks 2026-04-17, 05-01, 05-04, 05-08, 06-15, 08-07, Form 4s (12 of 29 in 12m). No transcript in the bundle.

1. What the business actually does

Dauch is American Axle & Manufacturing, renamed 2026-01-26. It makes driveline systems (axles, sideshafts, propshafts, differentials, electric drive units) and metal formed parts. On 2026-02-03 it bought Dowlais Group plc, parent of GKN Automotive and GKN Powder Metallurgy, for about $1.7 billion in cash plus roughly 117 million new shares, doubling the count (10-Q, MD&A). It remains a Detroit truck-axle business: GM was 44% of 2025 sales and 30% of H1 2026, Stellantis 13%, Ford 11%, and 76% of pre-merger hourly associates are unionized (10-Q; 10-K 2025, Item 1).

2. Why it is mispriced — the edge case

There is a real accounting artifact but no identifiable forced seller, so this cannot exceed WATCH. The artifact: a trailing screen reads CY2025 pre-merger figures (sales $5,836.7M, EBIT $112.3M, FCF $155.1M) against a post-merger enterprise value, giving 51.9x EV/EBIT on a share count up 100.2% with a GAAP H1 net loss of $99.3M (10-Q). The same EV is 4.1x guided Adjusted EBITDA.

What is missing is a seller. The stock is 25.9% off its high, 12-1 momentum is +0.7%, and it trades $18.5 million a day. The one plausible technical story, that the 117 million shares issued to former UK holders now sit in a Delaware issuer with a secondary LSE line, has no filing support beyond the company's own risk factor that dual listing may create arbitrage volatility (10-K 2025, Item 1A).

3. Unit economics and growth

Q2 sales were $2,955.6M against $1,536.2M, with about $1,439M from the acquisition, so the legacy book was roughly $1,517M, down 1.3% even including $35M of metal pass-through and FX help and $34M lost to the July 2025 AAM India sale (10-Q). The legacy asset was already shrinking: 2025 sales fell 4.7%, EBIT fell from $241.4M to $112.3M, and legacy Segment Adjusted EBITDA ran $743.2M, $749.2M and $693.3M in 2025, 2024 and 2023 (10-K 2025, Item 7).

Combined Adjusted EBITDA margin held at 13.2%, identical to Q2 2025 on nearly double the sales, while gross margin fell to 11.4% from 13.1% (8-K 2026-08-07). Tariffs cost about $30M of H1 earnings, guided to $10-20M net after unagreed customer recoveries; a June UAW stoppage cost about $8M (10-Q; 8-K 2026-06-15). Two caveats on the multiple: $70-80M of guided Adjusted EBITDA is equity income from the unconsolidated SDS China JV (which did pay a $50M dividend in H1), and about $60M comes from add-backs new to the 2026 definition.

4. Balance sheet and capital allocation

At 6/30/26: cash $880.8M, long-term debt net $5,025.9M, no current maturities, equity $1,509.7M. Net debt of $4,145M is 3.0x guided Adjusted EBITDA but 4.0x guided GAAP EBITDA of $995-1,055M; postretirement and other long-term liabilities add $1,400.1M. Liquidity is $2.5 billion with no significant maturities before 2029 after August's redemption of the 6.875% notes, at a 7.2% average rate and $340-360M of guided interest (10-Q). Credit agreements restrict dividends and buybacks; there are none.

Alignment looks weak. The bundle parsed 12 of 29 Form 4s; all 13 rows are grants, with zero open-market purchases. The long-term plan pays on adjusted free cash flow with 2026 threshold, target and maximum of $200M, $250M and $275M (DEF 14A 2026); management guides that measure to $260-325M, above its own maximum at the top end, on a metric that excludes the cash cost of the acquisition it is paid to integrate.

5. Management: said versus did

Guidance has been raised twice, the strongest fact in the file. Adjusted EBITDA went $1.30-1.40B to $1.30-1.425B to $1.36-1.425B, adjusted free cash flow $235-325M to $260-325M, synergies $50-75M to $60-75M against a stated run rate above $100M by end of year one, and the guided GAAP net loss improved from $(335)-(180)M to $(200)-(135)M (8-Ks 2026-05-08, 08-07). The raise is operational, not definitional: the revised add-back list was already in the Q1 bridge. Against that, the President of Axle Systems was terminated 2026-04-13 (8-K 2026-04-17), 2025 say-on-pay passed with "support below historical levels," and the CEO's LTI target rose from 575% to 700% of salary in August 2025, before closing (DEF 14A 2026).

6. Valuation

Base (50%): 2027 Adjusted EBITDA near $1.45B on a full year of Dowlais and the $100M synergy run rate against 2% annual legacy decline; 4.75x EV, net debt $4.0B, equity $2.9B or $12.20. Bear (30%): a 10% North American production downturn takes EBITDA to $1.15B with no deleveraging; 4.5x leaves $1.0B or $4.30. Bull (20%): EBITDA reaches $1.55B by 2028 and net debt falls to $3.6B; 5.5x gives $4.9B or $20.70. Probability weighted about $11.50, 73% above price, with a fat left tail because the equity is only 28% of enterprise value.

Reverse DCF: the price capitalizes the equity at $1.59 billion against guided adjusted free cash flow of $260-325 million, so on a 12% cost of equity it implies levered free cash flow declining about 6.5% a year in perpetuity. The offset is that on GAAP terms the company guides 2026 free cash flow to negative $90-105 million, after $360-420 million of acquisition, restructuring and integration payments and $160-170 million of cash taxes (8-K 2026-08-07; 10-Q). Debt rises in 2026; deleveraging is a 2027 story that has not started.

7. Catalysts and timeline

Q3 2026 results in late October are the first quarter without a work stoppage and the first clean read on the combined run rate. February 2027 brings 2027 guidance, the first full year with Dowlais, the first year the roughly $400 million of deal and integration cash cost should fall away, and confirmation of the synergy run rate. The 2026 USMCA review sits over the same window.

8. Risks and pre-registered kill criteria

Dominant risks: cyclical operating leverage on a stub equity, tariffs and USMCA, GM concentration, integration of a deal that doubled the company. 1. Full-year 2026 GAAP free cash flow worse than the guided negative $105 million, or 2027 GAAP free cash flow not guided positive. 2. Segment Adjusted EBITDA margin below 12.0% for two consecutive quarters (13.2% in Q2 2026; 12.0% is the comp plan's own target). 3. Net debt above 3.5x trailing Adjusted EBITDA at any quarter end (3.0x on the guide at 6/30/26). 4. Synergy run-rate guidance cut below $100 million, or 2027 restructuring plus integration cash payments guided above $260 million.

9. Verdict and summary

WATCH, conviction 3. Dauch is the old American Axle after it doubled itself by buying GKN, and the screen's 51.9x EV/EBIT is an artifact of reading pre-merger 2025 earnings against a post-merger enterprise value: the same $5.7 billion EV is 4.1x guided Adjusted EBITDA of $1.36-1.425 billion, a guide raised twice this year on synergies running ahead of plan. It is not an IDEA because nothing identifiable is selling a stock that sits 26% below its high on $18.5 million of daily volume, and because the cash story is a year away: the company's own outlook table guides 2026 GAAP free cash flow to negative $90-105 million after roughly $400 million of deal and integration payments and $160-170 million of cash taxes, so $4.1 billion of net debt rises this year rather than falls, against equity that is only 28% of enterprise value and a 13.2% margin an ordinary downturn would cut hard. No insider bought a share in the twelve months the bundle covers, and management is paid on an adjusted cash flow measure that excludes exactly the cash costs of the deal it is integrating. Wait for the February 2027 guide to show unadjusted free cash flow turning positive with the synergy run rate confirmed above $100 million; the same arithmetic is then worth roughly $12 rather than $6.67.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.